Clinical characterstics and outcomes of patients with BRAF-mutant advanced cancer in a phase I clinic: The University of Texas M. D. Anderson Cancer Center experience.
H. E. El-Osta
No relevant relationships to disclose
G. S. Falchook
Research Funding - GlaxoSmithKline
A. M. Tsimberidou
No relevant relationships to disclose
D. S. Hong
No relevant relationships to disclose
A. Naing
No relevant relationships to disclose
K. B. Kim
No relevant relationships to disclose
S. Wen
No relevant relationships to disclose
F. Janku
No relevant relationships to disclose
R. Kurzrock
Research Funding - AstraZeneca; Bayer; Genentech; GlaxoSmithKline